Quality of life as a criterion of disease modifying anti-rheumaticdrug and biological agents therapy efficacy: results of international and Russian studies
Main Authors: | V N Amirdjanova, E Y Kaigorodtseva, N A Savenkova, E L Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2009-04-01
|
Series: | Научно-практическая ревматология |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/598 |
Similar Items
-
Quality of life in patients with rheumatoid arthritis receiving anti-В cell therapy (results of international studies and Russia registry)
by: V N Amirdjanova, et al.
Published: (2008-12-01) -
Russian registry of patients receiving rituximab: results of pharmacoeconomic analysis
by: V N Amirdjanova, et al.
Published: (2009-02-01) -
Safety of using genetic engineering biological agents in rheumatoid arthritis
by: N V Chichasova, et al.
Published: (2010-03-01) -
DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01) -
EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)